What is the recommended dose of Levetiracetam (Syp Levera) in milliliters for a 4-year-old patient with a seizure disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Levetiracetam (Syp Levera) Dosing for a 4-Year-Old Child

For a 4-year-old child with epilepsy, start levetiracetam at 10 mg/kg twice daily (20 mg/kg/day total), increasing every 2 weeks by 10 mg/kg twice daily increments to a target dose of 30 mg/kg twice daily (60 mg/kg/day total). 1

Weight-Based Dosing Calculation

To determine the exact milliliter dose, you must first know the child's weight:

Formula: Total daily dose (mL/day) = [Daily dose (mg/kg/day) × patient weight (kg)] ÷ 100 mg/mL 1

Starting Dose (20 mg/kg/day)

  • Example for 15 kg child: (20 mg/kg/day × 15 kg) ÷ 100 = 3 mL/day → Give 1.5 mL twice daily 1
  • Example for 20 kg child: (20 mg/kg/day × 20 kg) ÷ 100 = 4 mL/day → Give 2 mL twice daily 1

Target Maintenance Dose (60 mg/kg/day)

  • Example for 15 kg child: (60 mg/kg/day × 15 kg) ÷ 100 = 9 mL/day → Give 4.5 mL twice daily 1
  • Example for 20 kg child: (60 mg/kg/day × 20 kg) ÷ 100 = 12 mL/day → Give 6 mL twice daily 1

Titration Schedule

Week 1-2: Start at 10 mg/kg twice daily (20 mg/kg/day total) 1

Week 3-4: Increase to 20 mg/kg twice daily (40 mg/kg/day total) 1

Week 5+: Increase to target 30 mg/kg twice daily (60 mg/kg/day total) 1

If the child cannot tolerate 60 mg/kg/day, the dose may be reduced, though clinical trial data showed a mean effective dose of 52 mg/kg/day in pediatric patients 1

Critical Administration Details

  • Use oral solution for children ≤20 kg body weight 1
  • Use a calibrated measuring device, NOT household teaspoons or tablespoons 1
  • Administer with or without food 1
  • Divide total daily dose into two equal doses given 12 hours apart 1

Clinical Context

Levetiracetam is FDA-approved for children ≥4 years old as adjunctive therapy for partial onset seizures 1. Pediatric studies demonstrate 39-52% of children achieve >50% seizure reduction, with 27% achieving seizure freedom for at least 4 weeks 2. The medication is generally well-tolerated, with the most common adverse effects being hyperactivity (48.5%), somnolence (36.4%), and irritability (33.3%), though most are mild in severity 2.

Common Pitfalls to Avoid

Never use household measuring spoons—they are inaccurate and can lead to significant dosing errors 1. Always provide caregivers with a calibrated oral syringe or dosing cup marked in milliliters.

Do not skip the titration schedule—rapid dose escalation increases the risk of behavioral adverse effects, particularly aggression and irritability 2. The 2-week titration intervals allow for tolerance development and adverse effect monitoring.

Monitor for behavioral changes closely—while levetiracetam has a favorable safety profile, 27% of children may develop aggressive behavior, which is the most common reason for discontinuation 2. However, some children paradoxically show behavioral improvements 3.

References

Research

Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2008

Research

Levetiracetam in the treatment of childhood epilepsy.

Neuropsychiatric disease and treatment, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.